Navigation Links
Amgen Announces 2014 First Quarter Dividend
Date:12/13/2013

can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign), difficulties or delays in manufacturing our products.  In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products.  Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.  We or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of
'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
2. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
3. Amgens Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
4. Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
5. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
6. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
7. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
8. Amgen To Participate At Citis 8th Annual Biotech Conference
9. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
10. Amgen to Highlight New Data at Upcoming ESC Congress 2013
11. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  According to the American Optometric ... spend on digital devices. An AOA survey reports that ... and 17 estimate they use an electronic device for ... AOA survey of parents revealed that only 40 percent ... for that same amount of time. Eye doctors are ...
(Date:7/22/2014)... July 22, 2014  Vernalis plc (LSE: VER) and Tris ... (POC) for CCP-08, the third programme to achieve ... collaboration. Under this collaboration, POC requires the successful ... pilot comparative study against an immediate release reference ... will make a milestone payment to Tris. ...
(Date:7/22/2014)... , July 22, 2014 /PRNewswire/ ... für umfassenden Schutz von Pharmazeuten und ...    Equashield ( http://www.equashield.com ... (Closed System Transfer Devices, CSTDs) für gefährliche Medikamente, ... Vertriebshändler und Hersteller von medizinischen Produkten, zu ...
Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... PARK, Calif., Sept. 14 Praxis EMR has submitted its ... EMRs to apply for HITECH certification in the country. Under ... in federal incentives if they can demonstrate "meaningful use" of ... the U.S. Department of Health and Human Services to test ...
... Reportlinker.com announces that a new market research ... Autistic Disorder - Pipeline Assessment and Market ... Autistic Disorder - Pipeline ... SummaryGlobalData, the industry analysis specialist, has released ...
Cached Medicine Technology:Praxis EMR Among First to Apply for HITECH Certification 2Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 3
(Date:7/23/2014)... Picnic Lunches, Residents of The Clare can now enjoy the ... still dining on the fabulous cuisine of Chef Hagop Hagopian. ... to the beach or museum and we love to make ... said Brian Hughes, director of dining services for The Clare. ... , Hagopian, the executive chef of The Clare is trained ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Print ... Print Audit Facilities Manager web portal. Facilities Manager ... releases of the software as well as numerous ... , Print Audit Facilities Manager is a powerful, ... to remotely collect meter reads, automate supplies fulfillment ...
(Date:7/22/2014)... July 22, 2014 As one alternative ... consumers to buy can now reduce or in some ... has released its cosmetic buying guide to help buyers ... http://cherrynews.com/best-nourishing-eye-serum . , This guide is meant for ... the different under eye circles that can appear. While ...
(Date:7/22/2014)... 2014 The market for beauty products ... through 2022, according to new industry reports. Women who ... benefit from a new guide published at the Cherry ... now available at http://cherrynews.com/best-nourishing-eye-serum . , This published ... to many of the top skin improvement products on ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Dr. Jeremy ... his surgical colleagues, have recently discussed the reasons for ... leaders in the periodontics profession are seeing the amount ... up exponentially. In fact, one surgeon reported that over ... implants. Although dental implants have a very high success ...
Breaking Medicine News(10 mins):Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3
... safe and well-tolerated for elderly patients with chronic lymphocytic ... their disease, researchers from The University of Texas M. ... annual meeting of the American Society of Hematology. , ... of activity against CLL in our phase II clinical ...
... Deaconess Hospital has entered an agreement with Omaha-based ... Medicare-eligible patients access to an expanded lineup of Medicare ... Patients who elect coverage through Deaconess can now ... including Mutual of Omaha, UnitedHealthcare, Coventry, CIGNA, Aetna, Pyramid ...
... to Start Exploring Their Shared Genetics , ... Mountain View, CA (PRWEB) ... personal genetics, today announced it is offering a Multiple Kit discount ... in a single order will save $200 on the first three kits ...
... The end of fall marks an exciting time,for ... their,professional careers. Fellows from around the world will gather ... Interventions (SCAI),Third Annual Interventional Cardiology Fall Fellows Course in ... Given the aging population and the increasing number ...
... to blame; experts cite risk of skin cancer , , ... states to restrict and limit indoor tanning by children ... a worrisome trend, because ultraviolet radiation, whether from the ... skin cancer, the most common malignancy in the United ...
... Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced today ... lorcaserin, its novel drug candidate for the treatment ... Obesity, the official peer reviewed journal,of The Obesity ... with lorcaserin, as compared to placebo, experienced,statistically significant ...
Cached Medicine News:Health News:Lenalidomide safe as single therapy for elderly CLL patients 2Health News:Deaconess Hospital Partners With Senior Market Sales to Expand Insurance Offering for Medicare-Eligible Patients 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 3Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 2Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 3Health News:Laws Governing Indoor Tanning by Teens Don't Work 2Health News:Laws Governing Indoor Tanning by Teens Don't Work 3Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 2Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 3Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 4Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 5
... the typical patient, right for the not-so-typical ... you have the ability to address the ... least expect themeven after implant. St. Jude ... to be prepared in almost any situation, ...
... The R4Mplus offers global companies a ... meet RFID compliance initiatives. With die-cast ... variety of connectivity options, and complex ... a super value. Plus, the fully ...
... combines enhanced memory, processing capacity, ... reliable all-metal construction. Proven platform ... print speed make it the ... value reliability, productivity, consistent print ...
... companies a cost-effective and dependable performer ... With die-cast metal construction, centralized printer/encoder ... and complex multi-language font support, the ... the fully integrated RFID reader/encoder supports ...
Medicine Products: